Albemarle Corporation
ALB is executing better than feared, but $133.99 still prices a cleaner lithium recovery than current volumes, pricing, and FY2025 profitability support.
ALB is not broken. It is just still too expensive for what the business has actually proven. The stock at $133.99 is no longer near capitulation levels. It sits 12.16% above the last month, but still -39.4% below the $221.00 52-week high and -13.1% below the $154.26 200-day average, which means the market has already staged a meaningful recovery trade without yet seeing a full earnings normalization. That setup matters. A bullish thesis at $72.58 would have been different from a bullish thesis here.
The core issue is that reported FY2025 fundamentals remain ugly: $5.1B of revenue, down 31.7%, EPS $-5.75, operating margin -25.0%, and net margin -22.4%. Bulls will rightly say those are stale trough numbers, and the recent quarter supports that argument. Q2 2026 was much better, with 31% YoY sales growth and $0.77B EBITDA at a 44.2% margin. But management also told investors not to extrapolate that quarter, explicitly guiding Q3 lower sequentially on both volume and pricing. For a commodity-sensitive stock, that matters more than a backward-looking beat streak.
The case depends on three things. First, lithium pricing has to stay tighter for longer. Management said inventories are low and physical markets remain tight, but ALB still expects only 225,000-235,000 tons LCE in Energy Storage this year, or flat to down 4% YoY after the CGP3 disruption. Second, Specialties has to keep carrying more of the load, and that segment is helping, with the FY26 sales guide raised to $1.4B-$1.6B and EBITDA to $275M-$325M. Third, the cost discipline that started in 2024 has to stick. So far it has. FCF $0.6B, capex $0.1B, and no buybacks are signs of maturity.
What the market may be mispricing is durability. ALB deserves credit for better execution, but not yet a valuation that assumes a smooth return to peak-cycle economics. The stock's 279.15x P/E versus 21.8x peers is a poor anchor because earnings are still distorted, but it still tells the right directional story: investors are paying up for recovery before the company has delivered a stable recovery. That leaves limited room for error if Q3 confirms weaker realized prices or if 2027 supply expands faster through DLE and competing sources.
Tight lithium inventories persist, realized pricing surprises to the upside, and ALB sustains near-Q2 profitability while CGP3 and Wodgina improve supply.
Execution stays decent but normalization in Specialties pricing and weaker Q3 Energy Storage limit earnings power, leaving ALB closer to the quant engine value.
Lithium pricing softens into 2027, Q3 weakness extends, and Energy Storage volumes stay near the low end of 225,000 tons LCE with margins compressing.
Quant call (SELL) diverges from analyst consensus (Strong Buy: 7 buy / 3 hold / 0 sell) — resolve explicitly.
The most dangerous thing is to buy something at the peak of its popularity.
Forward earnings power is the whole debate. The trailing 279.15x P/E is meaningless for a cyclical trough-to-recovery story, but even on forward earnings the stock looks expensive if FY26 volumes are only 225,000-235,000 tons LCE and Q3 pricing steps down sequentially. The moat today is still scale, processing know-how, and resource access, but over 3-5 years it looks less secure if direct lithium extraction broadens supply and customers diversify chemistries and sourcing, while AI is only an indirect demand tailwind through data-center power storage rather than a company-specific advantage. Regulation cuts both ways: the Salar de Atacama DLE permit for up to 6 trains could extend asset life, but it also raises execution and timing risk, so the stock still looks priced ahead of proof.
- $100.53 base-case price target implies -25.0% downside from $133.99, with valuation stretched at 279.15x P/E versus 21.8x peers.
- FY2025 revenue fell to $5.1B, down 31.7% YoY, while operating margin deteriorated to -25.0% from -11.8%.
- 2026 execution improved materially, with Q2 EBITDA $0.77B at a 44.2% margin, but FY26 Energy Storage volume guidance is only 225,000-235,000 tons LCE, or flat to down 4% YoY.
- Recent execution is better than the tape implies: ALB beat EPS in 4 of the last 5 quarters after the February 2026 miss, including +147.9% on 2026-05-06 and +17.2% on 2026-08-05.
- Q2 2026 showed real operating leverage, with EBITDA margin expanding to 44.2%, up 1,300 bps versus Q1 and 2,250 bps versus prior-year Q2.
- Management kept FY26 company ranges and said it expects the high end of the scenario ranges, supported by raised Specialties guidance of $1.4B-$1.6B sales and $275M-$325M EBITDA.
- Balance sheet stress is manageable, not acute: Debt/Equity 0.19, Current ratio 2.09, and FCF $0.6B give ALB time to ride through lithium volatility.
- The earnings base is still distorted by commodity recovery, not normalized profitability: FY2025 EPS was $-5.75, net margin -22.4%, and operating margin -25.0%.
- Management explicitly guided to weaker Q3, saying, "For the third quarter, net sales and adjusted EBITDA are expected to decrease sequentially due to lower sales volumes and assuming that pricing is lower sequentially for the quarter as it stands today."
- Energy Storage volume guidance was cut to 225,000-235,000 tons LCE, or flat to down 4% YoY, after the CGP3 fire, which weakens the case for a clean volume-led rebound.
- Valuation support is shaky because peer dispersion is extreme at 875.3x, making the peer-based multiple framework unreliable for a cyclical, loss-making lithium producer.
| Metric | Value | Context |
|---|---|---|
| Current price | $133.99 | Reference price for the $100.53 target |
| Quant price target | $100.53 | -25.0% vs current, Medium confidence, basis: earnings_growth_blend |
| FY2025 revenue | $5.1B | -31.7% YoY, severe downturn still visible in reported results |
| FY2025 EPS | $-5.75 | Loss-making year, 152.6% YoY deterioration |
| FY2025 operating margin | -25.0% | Worse than prior FY -11.8% |
| Valuation | 279.15x P/E, 2.68x P/S, 1.54x P/B | P/E far above peer average 21.8x, P/S modestly above 2.4x peers |
| Balance sheet | 0.19 Debt/Equity, 3.55 Debt/EBITDA, 2.09 Current ratio | Liquidity and leverage are manageable, not pristine |
| Cash generation | $0.6B FCF | Supported by $0.1B capex and 80%+ cash conversion in Q2 |
| Q2 2026 EBITDA | $0.77B | 44.2% margin, up 1,300 bps vs Q1 and 2,250 bps vs prior-year Q2 |
| FY26 Energy Storage volume guide | 225,000-235,000 tons LCE | Flat to down 4% YoY, constrained by CGP3 disruption |
| Specialties FY26 guide | $1.4B-$1.6B sales, $275M-$325M EBITDA | Outlook raised on stronger pricing and volumes |
| Price action | -39.4% vs 52-week high, -13.1% vs 200-day average | Off the lows but not washed out, with 9.52% short interest |
The biggest risk to a SELL call is that a still-tight lithium market drives pricing above management's current assumptions, because Q2 already showed 31% YoY sales growth and Q2 EBITDA margin 44.2%.
The next key catalyst is Q3 results on November 4, 2026, when investors will see whether the guided sequential Energy Storage slowdown is merely timing-related or the start of another pricing reset.
Ownership is crowded and institutionally controlled, with the top three holders at 81.8% and insider ownership only 0.3%, which can amplify moves when sector sentiment shifts. Short interest is notable at 9.52% of shares, or 11.2M shares with 5 days-to-cover, so there is still squeeze fuel if lithium prices keep surprising up. Options positioning is mildly supportive near term, with a positive GEX regime and zero-gamma at $129.45, slightly below spot, which can dampen volatility unless the stock breaks decisively away from that level.
Core lithium business, FY26 volume guide 225,000-235,000 tons LCE, with Q3 expected down sequentially on lower volumes, lower pricing, and spodumene timing.
Raised outlook, with $275M-$325M FY26 EBITDA supported by stronger pricing and volumes, though management expects Q3 bromine pricing to normalize from Q2 peak.
Key operational exposure includes Australia at Greenbushes and Wodgina, and Chile at Salar de Atacama, with the DLE permit filed for up to 6 trains.
ALB kept FY26 ranges but flagged high-end of scenario ranges as specialties strength offsets softer Q3 energy storage.
Execution has improved, but credibility is mixed rather than fully restored. On the 2024 Q3 call management promised $300M-$400M of cost and productivity improvements for 2025+, a $40M-$50M exit-2024 savings run rate, and a sharp capex reset to $800M-$900M for FY25; the current data show that discipline did come through, with capex now just $0.1B and FCF $0.6B, while 2026 Q2 EBITDA reached $0.77B at a 44.2% margin. But management also leaned in 2024 on Energy Storage volume growth of more than 20% and better Q4 margins as costs rolled through, and the path since then has been uneven, with FY2025 revenue down 31.7%, EPS at $-5.75, and three quarterly misses between 2024-11-06 and 2026-02-11 before the recent run of beats. Strategy has shifted from growth-at-scale to cash discipline and selective brownfield progress, which is the right change, but the record says management deserves some credit for cost control and less credit on forecasting cycle durability.
We are maintaining our total company outlook ranges and expect to come in at the high end of the scenario ranges due to strong year-to-date performance and an increased specialties outlook.
For the third quarter, net sales and adjusted EBITDA are expected to decrease sequentially due to lower sales volumes and assuming that pricing is lower sequentially for the quarter as it stands today.
For the full year, energy storage sales volumes are now expected to be in the range of 225,000 to 235,000 tons LCE or flat to down 4% year-over-year.
Our strong start to 2026 continued in the second quarter, supported by disciplined execution and improving conditions across our key markets.
Needed supply increases are coming to market slower than demand growth due to limited spodumene availability, temporary disruptions in shipments from Africa and slower-than-expected ramp-up of Chinese lepidolite mines. And as a result, inventories are low and the physical lithium market remains tight.
ALB's moat rests on hard-to-replicate lithium resource positions, conversion capacity, and customer qualification in battery-grade chemicals and bromine specialties. That moat is real today because supply remains tight and scale matters, but durability is only moderate because lithium is still a commodity-heavy business where price often overwhelms process advantage, and new supply technologies like DLE can narrow incumbent advantages over the next 3-5 years.
Capital allocation has become far more disciplined than it was in the prior upcycle. ALB generated $0.6B FCF on only $0.1B capex, paid $0.1B in dividends, and did no buybacks, which is the right posture while debt metrics are still rebuilding. The key question is whether this discipline holds if lithium prices stay firm, because Albemarle's weak historical tendency was to spend heavily into growth projects before returns were proven.
ALB rates SELL, Medium conviction. The company has repaired more than the market expected operationally, but the stock now asks investors to pay ahead for a sustained lithium recovery that management itself is not yet confirming quarter to quarter. The right stance is to respect the stronger execution while still fading the valuation at $133.99 against a $100.53 base case. A move to HOLD or BUY would require either a materially lower stock price or proof that post-Q3 pricing and volumes can support 2027 earnings power without another reset.
≣ Full research note tap to expand
Executive Summary
SELL, Medium conviction. Rated SELL, Medium conviction. Albemarle has clearly improved operating execution in 2026, shown by two large EPS beats and Q2 EBITDA of $0.77B at a 44.2% margin, but the stock has already rebounded off the lows while the company still carries a FY2025 EPS loss of $-5.75, a 279.15x P/E, and management is explicitly guiding to a weaker sequential Q3 in Energy Storage. The quant engine's $100.53 target, or -25.0% from $133.99, remains the right base case because the market is capitalizing near-cycle earnings as if the lithium recovery is already durable.
Investment Thesis
ALB is not broken. It is just still too expensive for what the business has actually proven. The stock at $133.99 is no longer near capitulation levels. It sits 12.16% above the last month, but still -39.4% below the $221.00 52-week high and -13.1% below the $154.26 200-day average, which means the market has already staged a meaningful recovery trade without yet seeing a full earnings normalization. That setup matters. A bullish thesis at $72.58 would have been different from a bullish thesis here.
The core issue is that reported FY2025 fundamentals remain ugly: $5.1B of revenue, down 31.7%, EPS $-5.75, operating margin -25.0%, and net margin -22.4%. Bulls will rightly say those are stale trough numbers, and the recent quarter supports that argument. Q2 2026 was much better, with 31% YoY sales growth and $0.77B EBITDA at a 44.2% margin. But management also told investors not to extrapolate that quarter, explicitly guiding Q3 lower sequentially on both volume and pricing. For a commodity-sensitive stock, that matters more than a backward-looking beat streak.
The case depends on three things. First, lithium pricing has to stay tighter for longer. Management said inventories are low and physical markets remain tight, but ALB still expects only 225,000-235,000 tons LCE in Energy Storage this year, or flat to down 4% YoY after the CGP3 disruption. Second, Specialties has to keep carrying more of the load, and that segment is helping, with the FY26 sales guide raised to $1.4B-$1.6B and EBITDA to $275M-$325M. Third, the cost discipline that started in 2024 has to stick. So far it has. FCF $0.6B, capex $0.1B, and no buybacks are signs of maturity.
What the market may be mispricing is durability. ALB deserves credit for better execution, but not yet a valuation that assumes a smooth return to peak-cycle economics. The stock's 279.15x P/E versus 21.8x peers is a poor anchor because earnings are still distorted, but it still tells the right directional story: investors are paying up for recovery before the company has delivered a stable recovery. That leaves limited room for error if Q3 confirms weaker realized prices or if 2027 supply expands faster through DLE and competing sources.
Key Metrics
| Metric | Value | Context |
|---|---|---|
| Current price | $133.99 | Reference price for the $100.53 target |
| Quant price target | $100.53 | -25.0% vs current, Medium confidence, basis: earnings_growth_blend |
| FY2025 revenue | $5.1B | -31.7% YoY, severe downturn still visible in reported results |
| FY2025 EPS | $-5.75 | Loss-making year, 152.6% YoY deterioration |
| FY2025 operating margin | -25.0% | Worse than prior FY -11.8% |
| Valuation | 279.15x P/E, 2.68x P/S, 1.54x P/B | P/E far above peer average 21.8x, P/S modestly above 2.4x peers |
| Balance sheet | 0.19 Debt/Equity, 3.55 Debt/EBITDA, 2.09 Current ratio | Liquidity and leverage are manageable, not pristine |
| Cash generation | $0.6B FCF | Supported by $0.1B capex and 80%+ cash conversion in Q2 |
| Q2 2026 EBITDA | $0.77B | 44.2% margin, up 1,300 bps vs Q1 and 2,250 bps vs prior-year Q2 |
| FY26 Energy Storage volume guide | 225,000-235,000 tons LCE | Flat to down 4% YoY, constrained by CGP3 disruption |
| Specialties FY26 guide | $1.4B-$1.6B sales, $275M-$325M EBITDA | Outlook raised on stronger pricing and volumes |
| Price action | -39.4% vs 52-week high, -13.1% vs 200-day average | Off the lows but not washed out, with 9.52% short interest |
Financial Strength
The balance sheet is not the problem. Debt/Equity of 0.19 and a 2.09 current ratio give Albemarle enough flexibility to absorb cyclical volatility, while Debt/EBITDA of 3.55 is elevated but manageable for a business that just posted $0.77B of quarterly EBITDA. The bigger issue is earnings quality through the cycle. FY2025 margins were deeply negative, so investors have to underwrite a rebound, not a stable base. The encouraging part is that cash generation has recovered faster than accounting earnings, with $0.6B FCF and tight capex, which lowers balance-sheet risk even if it does not eliminate valuation risk.
Competitive Position
ALB's moat rests on hard-to-replicate lithium resource positions, conversion capacity, and customer qualification in battery-grade chemicals and bromine specialties. That moat is real today because supply remains tight and scale matters, but durability is only moderate because lithium is still a commodity-heavy business where price often overwhelms process advantage, and new supply technologies like DLE can narrow incumbent advantages over the next 3-5 years.
Management & Guidance
Management's current guidance is balanced, not promotional. CFO Neal Sheorey said, "We are maintaining our total company outlook ranges and expect to come in at the high end of the scenario ranges due to strong year-to-date performance and an increased specialties outlook," but also warned, "For the third quarter, net sales and adjusted EBITDA are expected to decrease sequentially due to lower sales volumes and assuming that pricing is lower sequentially for the quarter as it stands today." That makes the guide more credible than a simple beat-and-raise. The issue is not honesty, it is visibility. With Energy Storage volumes now 225,000-235,000 tons LCE and a known $70M-$90M supply-chain headwind, ALB is still highly exposed to realized lithium pricing over the next two quarters.
Segment Analysis
- Energy Storage (N/A): Core lithium business, FY26 volume guide 225,000-235,000 tons LCE, with Q3 expected down sequentially on lower volumes, lower pricing, and spodumene timing.
- Specialties ($1.4B-$1.6B FY26 sales guide): Raised outlook, with $275M-$325M FY26 EBITDA supported by stronger pricing and volumes, though management expects Q3 bromine pricing to normalize from Q2 peak.
- Geography (N/A): Key operational exposure includes Australia at Greenbushes and Wodgina, and Chile at Salar de Atacama, with the DLE permit filed for up to 6 trains.
Capital Allocation
Capital allocation has become far more disciplined than it was in the prior upcycle. ALB generated $0.6B FCF on only $0.1B capex, paid $0.1B in dividends, and did no buybacks, which is the right posture while debt metrics are still rebuilding. The key question is whether this discipline holds if lithium prices stay firm, because Albemarle's weak historical tendency was to spend heavily into growth projects before returns were proven.
Management Execution & Track Record
Execution has improved, but credibility is mixed rather than fully restored. On the 2024 Q3 call management promised $300M-$400M of cost and productivity improvements for 2025+, a $40M-$50M exit-2024 savings run rate, and a sharp capex reset to $800M-$900M for FY25; the current data show that discipline did come through, with capex now just $0.1B and FCF $0.6B, while 2026 Q2 EBITDA reached $0.77B at a 44.2% margin. But management also leaned in 2024 on Energy Storage volume growth of more than 20% and better Q4 margins as costs rolled through, and the path since then has been uneven, with FY2025 revenue down 31.7%, EPS at $-5.75, and three quarterly misses between 2024-11-06 and 2026-02-11 before the recent run of beats. Strategy has shifted from growth-at-scale to cash discipline and selective brownfield progress, which is the right change, but the record says management deserves some credit for cost control and less credit on forecasting cycle durability.
Positioning & Flows
Ownership is crowded and institutionally controlled, with the top three holders at 81.8% and insider ownership only 0.3%, which can amplify moves when sector sentiment shifts. Short interest is notable at 9.52% of shares, or 11.2M shares with 5 days-to-cover, so there is still squeeze fuel if lithium prices keep surprising up. Options positioning is mildly supportive near term, with a positive GEX regime and zero-gamma at $129.45, slightly below spot, which can dampen volatility unless the stock breaks decisively away from that level.
Bull Case
- Recent execution is better than the tape implies: ALB beat EPS in 4 of the last 5 quarters after the February 2026 miss, including +147.9% on 2026-05-06 and +17.2% on 2026-08-05.
- Q2 2026 showed real operating leverage, with EBITDA margin expanding to 44.2%, up 1,300 bps versus Q1 and 2,250 bps versus prior-year Q2.
- Management kept FY26 company ranges and said it expects the high end of the scenario ranges, supported by raised Specialties guidance of $1.4B-$1.6B sales and $275M-$325M EBITDA.
- Balance sheet stress is manageable, not acute: Debt/Equity 0.19, Current ratio 2.09, and FCF $0.6B give ALB time to ride through lithium volatility.
Bear Case
- The earnings base is still distorted by commodity recovery, not normalized profitability: FY2025 EPS was $-5.75, net margin -22.4%, and operating margin -25.0%.
- Management explicitly guided to weaker Q3, saying, "For the third quarter, net sales and adjusted EBITDA are expected to decrease sequentially due to lower sales volumes and assuming that pricing is lower sequentially for the quarter as it stands today."
- Energy Storage volume guidance was cut to 225,000-235,000 tons LCE, or flat to down 4% YoY, after the CGP3 fire, which weakens the case for a clean volume-led rebound.
- Valuation support is shaky because peer dispersion is extreme at 875.3x, making the peer-based multiple framework unreliable for a cyclical, loss-making lithium producer.
Valuation & Price Target
Engine price target $100.53 (-25% vs current), Medium confidence.
- P/E Multiple: $8.9 (4% weight)
- P/S Multiple: $86 (20% weight)
- Quality-adjusted: $132.92 (20% weight)
This rating aligns with the quant baseline: SELL, Medium conviction. The quant target of $100.53 makes sense because the quality-adjusted anchor at $132.92 sits close to the current stock price, while the earnings-based methods are much lower and the peer set is noisy, with average P/E 21.8 but a huge 875.3x dispersion that weakens the case for arguing ALB deserves a premium multiple here. The one reason not to be more negative is that fundamentals are improving faster than FY2025 numbers suggest, shown by Q2 EBITDA $0.77B, 44.2% margin, and recent EPS beats; still, that is not enough to override management's own warning for a softer Q3 and a flat-to-down Energy Storage volume year. Sell-side consensus remains Strong Buy, 7 buy / 3 hold / 0 sell, but that signal is low quality here and looks anchored to a lithium recovery narrative more than to current valuation discipline.
Risk Assessment
Risk score 46/100 (Moderate). The biggest risk to a SELL call is that a still-tight lithium market drives pricing above management's current assumptions, because Q2 already showed 31% YoY sales growth and Q2 EBITDA margin 44.2%.
The Bottom Line
ALB rates SELL, Medium conviction. The company has repaired more than the market expected operationally, but the stock now asks investors to pay ahead for a sustained lithium recovery that management itself is not yet confirming quarter to quarter. The right stance is to respect the stronger execution while still fading the valuation at $133.99 against a $100.53 base case. A move to HOLD or BUY would require either a materially lower stock price or proof that post-Q3 pricing and volumes can support 2027 earnings power without another reset.
Go deeper in the app
Live charts, options analytics, the full earnings-call breakdown, price alerts, and every other stock — updated in real time.
Get Tickr